Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-19 11:04 am Sale | 2021-12-31 | 13G | Applied Genetic Technologies Corporation AGTC | Empery Asset Management, LP | 2,244,292 4.990% | -1,688,292 (-42.93%) | Filing History |
| 2022-01-19 11:03 am Purchase | 2021-12-31 | 13G | enVVeno Medical Corporation NVNO | Empery Asset Management, LP | 471,579 4.740% | 471,579 (New Position) | Filing History |
| 2022-01-19 10:48 am Sale | 2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Empery Asset Management, LP | 336 0.440% | -3,664 (-91.61%) | Filing History |
| 2022-01-19 10:46 am Purchase | 2021-12-31 | 13G | Envirotech Vehicles, Inc. EVTV | Empery Asset Management, LP | 2,014 2.610% | 2,014 (New Position) | Filing History |
| 2022-01-19 10:44 am Sale | 2021-12-31 | 13G | Caladrius Biosciences, Inc. CLBS | Empery Asset Management, LP | 167,024 4.020% | -62,908 (-27.36%) | Filing History |
| 2022-01-18 11:21 am Unchanged | 2021-12-31 | 13G | Viveve Medical, Inc. VIVE | Empery Asset Management, LP | 1,029,411 4.990% | 0 (Unchanged) | Filing History |
| 2022-01-18 11:19 am Purchase | 2021-12-31 | 13G | Timber Pharmaceuticals, Inc. TMBR | Empery Asset Management, LP | 197,331 4.990% | 15,625 (+8.60%) | Filing History |
| 2022-01-18 11:17 am Purchase | 2021-12-31 | 13G | Opus Genetics, Inc. IRD | Empery Asset Management, LP | 3,063,498 4.990% | 384,615 (+14.36%) | Filing History |
| 2022-01-18 11:14 am Purchase | 2021-12-31 | 13G | Castor Maritime Inc. CTRM | Empery Asset Management, LP | 306,786 3.300% | 306,786 (New Position) | Filing History |
| 2022-01-18 11:12 am Unchanged | 2021-12-31 | 13G | Ring Energy, Inc. REI | Empery Asset Management, LP | 21,428,500 4.990% | 0 (Unchanged) | Filing History |
| 2022-01-13 10:38 am Sale | 2021-12-31 | 13G | Red Cat Holdings, Inc. RCAT | Empery Asset Management, LP | 0 0.000% | -3,000,000 (Position Closed) | Filing History |
| 2022-01-13 10:37 am Sale | 2021-12-31 | 13G | Kiromic BioPharma, Inc. KRBP | Empery Asset Management, LP | 0 0.000% | -33,333 (Position Closed) | Filing History |
| 2022-01-13 10:36 am Sale | 2021-12-31 | 13G | Second Sight Medical Products, Inc. EYES | Empery Asset Management, LP | 0 0.000% | -1,100,000 (Position Closed) | Filing History |
| 2022-01-13 10:36 am Sale | 2021-12-31 | 13G | Atossa Therapeutics, Inc. ATOS | Empery Asset Management, LP | 1,312,500 1.030% | -3,448,000 (-72.43%) | Filing History |
| 2022-01-13 10:35 am Sale | 2021-12-31 | 13G | Applied DNA Sciences, Inc. APDN | Empery Asset Management, LP | 0 0.000% | -32 (Position Closed) | Filing History |
| 2022-01-13 10:32 am Sale | 2021-12-31 | 13G | 22nd Century Group, Inc. XXII | Empery Asset Management, LP | 0 0.000% | -14 (Position Closed) | Filing History |
| 2022-01-13 10:31 am Sale | 2021-12-31 | 13G | ENGlobal Corporation ENG | Empery Asset Management, LP | 0 0.000% | -297,619 (Position Closed) | Filing History |
| 2022-01-13 10:31 am Sale | 2021-12-31 | 13G | VirTra, Inc. VTSI | Empery Asset Management, LP | 0 0.000% | -1,000,000 (Position Closed) | Filing History |
| 2022-01-13 10:30 am Sale | 2021-12-31 | 13G | ION Geophysical Corporation IOGPQ | Empery Asset Management, LP | 835 0.000% | -995,832 (-99.92%) | Filing History |
| 2022-01-13 10:30 am Sale | 2021-12-31 | 13G | Aethlon Medical, Inc. AEMD | Empery Asset Management, LP | 131 0.680% | -1,604 (-92.44%) | Filing History |